The industry is experiencing stable expansion, supported by rising pet healthcare awareness and continuous product innovation. The landscape is evolving with increasing demand for effective parasite control solutions across companion animals, particularly dogs and cats. Growth is further strengthened by expanding veterinary infrastructure and improved access to pet medicines across both developed and emerging regions. The Pet Anthelmintic Drugs Market is projected to grow at a CAGR of 5.5% from 2026 to 2034 , reflecting steady expansion driven by rising demand for effective parasite control and improved pet healthcare awareness. This industry is segmented by target pathogen and distribution channel, offering a comprehensive understanding of its operational structure. Key pathogens include Ascaris Lumbricoides, Trichuris Trichiura, Enterobius Vermicularis, and Ancylostoma Duodenale, while major distribution channels include veterinary pharmacies and veterinary hospit...